Feeney 1997.

Methods	A patient report of af 13‐year old boy developing a tonic‐clonic ictal event on sertraline and methylphenidate treatment
Participants	Diagnosis of ADHD: DSM‐III (subtype: not stated) Age: 13 years old IQ: > 70 Sex: male Ethnicity: unknown Country: USA Comorbidity: depression Comedication: sertraline Sociodemographics: unknown
Interventions	Methylphenidate type: not stated Methylphenidate dosage: 80 mg/day (1.8 mg/kg/day) Administration schedule: not stated Duration of treatment: 10 months Treatment compliance: not stated
Outcomes	Non‐serious adverse events: No significant side effects for approximately 10 months
Notes	Funding/vested interests: not stated Authors' affiliations: Wright State University, School of Medicine, Dayton, Ohio Key conclusions of the study authors: first reported seizure in a patient with combined methylphenidate and sertraline treatment Comments from the study authors: more research is needed Supplemental information regarding ADHD diagnosis and IQ received through personal email correspondence with the authors in September 2013 (Klykylo 2013 [pers comm])